ArticleNoro psikiyatri arsivi2025
The Effect of Dual Diagnosis of Substance Use Disorders on Circadian Rhythm and Sleep Quality in Patients with Bipolar Disorder.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In this study, it was aimed to evaluate the effect of comorbid substance use disorders (SUD), sleep quality and circadian rhythm in patients with type 1 bipolar disorder (BD) in the euthymic period. Method: A total of 100 patients with a diagnosis of BD were divided into two groups of 50 patients each: the group with the sole diagnosis of BD (Group 1) and the group with the secondary diagnosis of SUD (Group 2). Structured Clinical Interview for DSM-5 (R) Disorders - Clinician Version (SCID-5-CV) conducted with 100 patients in the remission period for diagnostic clarity and identification of the SUD comorbidity. Sociodemographic Data Form, Young Mania Rating Scale (YMRS), Hamilton Depression Rating Scale (HDRS), Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Morningness Eveningness Questionnaire (MEQ) were used. Results: Groups were compared in terms of sleep quality and circadian rhythm characteristics; PSQI and ESS to evaluate sleep quality and daytime sleepiness; MEQ and BRIAN were used to determine chronotype and biological rhythm characteristics. Pittsburgh sleep quality index showing decreased sleep quality in group 2, ESS showing increased sleepiness and BRIAN showing biological rhythm irregularity were significantly higher (p<0.05). There was no significant difference between both groups in MEQ, which determined the chronotype preference. In addition, further comparisons were made by dividing Group 2 according to dominant substance use as alcohol, cannabis and other (amphetamine, opiate) Sleep (p=0.011) and social subscale values (p<0.001) from the BRIAN subscales of Group 1 were lower than in the cannabis group. The PSQI value of Group 1 was lower than that of Cannabis and other groups (p<0.001). In addition, the MEQ value of Group 1 was found to be lower than in the alcohol group (p=0.007). The evening chronotype was more prevalent in Group 1 and the morning chronotype was more prevalent in the patients with comorbid alcohol use disorder. Conclusion: It was determined that dual diagnosis of SUD negatively affected sleep quality, increased daytime sleepiness and caused deterioration in circadian rhythm, and there was no significant change in chronotype preference in patients with BD. In addition, in patients accompanied by cannabis use; it was determined that there was a greater deterioration in biological rhythm and sleep quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.